Publications & Reports

Efficacy trials of biomedical strategies to prevent HIV infection.

Kaldor JM, Guy RJ, Wilson D
National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia. Jkaldor@nchecr.unsw.edu.au

Abstract

PURPOSE OF REVIEW: The aim of this article is to outline key challenges facing the conduct of efficacy trials for biomedical strategies to prevent HIV infection. RECENT FINDINGS: The past 2-3 years have seen tumultuous development in this field. There have been disappointing findings in efficacy trials of vaginal microbicides, vaccines, the diaphragm and suppressive therapy for herpes, but a major breakthrough with the evidence that male circumcision prevents acquisition of infection. Meanwhile, clarity has started to emerge on a number of issues regarding trial conduct, including provision of standard of care, involvement of communities, and preparation for implementing effective interventions. SUMMARY: HIV prevention practice must continue to rely on condom promotion and other established strategies while biomedical approaches continue to be assessed and their implementation strategies evolve.

Publication

  • Journal: Current Opinion in HIV and AIDS
  • Published: 01/07/2008
  • Volume: 3
  • Issue: 4
  • Pagination: 504-508

Health Issue